A Phase 3 Lot-consistency Clinical Trial of Live Attenuated Varicella Vaccine
Clinical trial NCT03555071 · COMPLETED
Trial details
- NCT number
- NCT03555071
- Sponsor
- Sinovac (Dalian) Vaccine Technology Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-07
- Primary completion
- 2017-05-20
- Enrollment
- 1197
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.